We are live on ! Find out more
CAM

Cresset Asset Management Portfolio holdings

AUM $23.1B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
AUM
$25.9B
AUM Growth
-$54.9B
Cap. Flow
-$54.7B
Cap. Flow %
-211.1%
Top 10 Hldgs %
53.52%
Holding
2,024
New
125
Increased
1,041
Reduced
518
Closed
229

Sector Composition

Rank Sector Weight
1 Technology 13.57%
2 Healthcare 3.62%
3 Financials 3.01%
4 Communication Services 2.77%
5 Consumer Discretionary 2.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNW icon
1526
Genworth Financial
GNW
$3.75B
$246K ﹤0.01%
42,049
-120
-0.3% -$693
PXF icon
1527
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.94B
$246K ﹤0.01%
5,653
+155
+3% +$6.98K
CAR icon
1528
Avis
CAR
$4.9B
$245K ﹤0.01%
+1,366
New +$296K
EXPO icon
1529
Exponent
EXPO
$3.28B
$245K ﹤0.01%
2,867
+678
+31% +$61.3K
IHF icon
1530
iShares US Healthcare Providers ETF
IHF
$1.27B
$245K ﹤0.01%
4,975
KROS icon
1531
Keros Therapeutics
KROS
$212M
$245K ﹤0.01%
7,682
LKFN icon
1532
Lakeland Financial Corp
LKFN
$1.52B
$245K ﹤0.01%
5,158
+554
+12% +$28.6K
PINC
1533
DELISTED
Premier
PINC
$245K ﹤0.01%
+11,386
New +$284K
EME icon
1534
Emcor
EME
$35.7B
$244K ﹤0.01%
+1,162
New +$243K
OMF icon
1535
OneMain Financial
OMF
$7.27B
$244K ﹤0.01%
6,097
+531
+10% +$22.7K
OGN icon
1536
Organon & Co
OGN
$3.58B
$244K ﹤0.01%
14,069
+1,986
+16% +$41.4K
ASND icon
1537
Ascendis Pharma A/S
ASND
$16.8B
$244K ﹤0.01%
+2,605
New +$244K
STN icon
1538
Stantec
STN
$8.35B
$242K ﹤0.01%
+3,730
New +$248K
DIV icon
1539
Global X SuperDividend US ETF
DIV
$775M
$242K ﹤0.01%
14,943
GAP
1540
The Gap Inc
GAP
$7.74B
$241K ﹤0.01%
22,706
+520
+2% +$5.3K
FOUR icon
1541
Shift4
FOUR
$3.41B
$241K ﹤0.01%
+4,356
New +$266K
SPSB icon
1542
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
$240K ﹤0.01%
8,185
+201
+3% +$5.9K
NAD icon
1543
Nuveen Quality Municipal Income Fund
NAD
$2.77B
$239K ﹤0.01%
23,558
+3,024
+15% +$32.9K
AVK
1544
Advent Convertible and Income Fund
AVK
$563M
$238K ﹤0.01%
23,280
-32,193
-58% -$357K
ITA icon
1545
iShares US Aerospace & Defense ETF
ITA
$15B
$238K ﹤0.01%
2,238
-151
-6% -$17.2K
FIX icon
1546
Comfort Systems
FIX
$58.9B
$235K ﹤0.01%
+1,379
New +$242K
SPXL icon
1547
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
$235K ﹤0.01%
3,000
FLYW icon
1548
Flywire
FLYW
$2.11B
$234K ﹤0.01%
+7,352
New +$235K
URGN icon
1549
UroGen Pharma
URGN
$2.26B
$234K ﹤0.01%
16,716
-477
-3% -$7.66K
FCN icon
1550
FTI Consulting
FCN
$4.17B
$234K ﹤0.01%
1,312
+63
+5% +$11.7K

Similar funds

Cresset Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Cresset Asset Management held 2,024 positions worth $25.9B, down 68% from $80.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Cresset Asset Management withdrew a net $54.7B in Q3 2023, closing 229 positions and reducing 518 holdings. Its most notable exit was AFC Gamma, an estimated $8.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.2% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Cresset Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $75.1M.

  • Cresset Asset Management's largest Q3 2023 buy was iShares 0-3 Month Treasury Bond ETF: 745,605 shares worth $75.1M.
  • Cresset Asset Management added most to Invesco S&P 500 Equal Weight ETF in Q3 2023, an estimated $88.2M increase.
  • Cresset Asset Management's biggest Q3 2023 reduction was Arista Networks, cutting an estimated $87.1M.
  • Cresset Asset Management fully exited AFC Gamma in Q3 2023, selling an estimated $8.34M.
  • Cresset Asset Management's ten largest holdings make up 54% of its $25.9B portfolio in Q3 2023.
  • Cresset Asset Management opened 125 new positions and closed 229 in Q3 2023.
  • Cresset Asset Management's portfolio value fell 68% quarter-over-quarter to $25.9B.

Based on Cresset Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.